{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:42:37Z","timestamp":1784713357531,"version":"3.55.0"},"reference-count":13,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dan Med J"],"abstract":"<jats:p>INTRODUCTION. Pathological crying and\/or laughing (pseudobulbar affect (PBA)) are socially debilitating symptoms seen in many neurological diseases, such as stroke, multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). One method for measuring the degree of PBA is the Center for Neurologic Study-Lability Scale (CNS-LS), a seven-item questionnaire validated for quantifying symptoms and supporting PBA diagnoses in ALS and MS. The aim of this study was to provide a Danish translation of the CNS-LS inspired by international guidelines on cross-cultural translation and adaptation of self-report measurements.\n\nMETHODS. Through a six-step process, the CNS-LS was translated and back-translated by four certified translators, followed by an expert committee examination. The translation was then field-tested by interviewing patients with ALS and MS after they had completed the CNS-LS. If at least 20% of participants found an item \u201dunclear\u201d, it would be reevaluated.\n\nRESULTS. Twelve patients with ALS patients and 30 patients with MS were tested and interviewed. None of the questionnaire items exceeded the 20% threshold for lack of clarity.\n\nCONCLUSION. We present a Danish translation of the CNS-LS to facilitate better diagnosis and quantification of PBA symptoms in Danish patients with ALS or MS.\n\nFUNDING. This study received funding from the PhD fellowship grant of Neuroscience Academy Denmark.\n\nTRIAL REGISTRATION. Not relevant.<\/jats:p>","DOI":"10.61409\/a07240497","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T06:02:12Z","timestamp":1746770532000},"page":"1-7","source":"Crossref","is-referenced-by-count":1,"title":["An adapted Danish translation of the Center for Neurologic Study Lability scale"],"prefix":"10.61409","author":[{"given":"Christian H.","family":"Steenkj\u00e6r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia B.","family":"Heintzelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabella","family":"Ob\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grethe","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob U.","family":"Blicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"40208","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"King RR, Reiss JP. The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegeneration. Degener Neurol Neuromuscul Dis. 2013;3:23-31. https:\/\/doi.org\/10.2147\/DNND.S34160","DOI":"10.2147\/DNND.S34160"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Cummings JL, Gilbart JW, Andersen G. Pseudobulbar affect - a disabling but under-recognised consequence of neurological disease and brain injury. Eur Neurol Rev. 2013;8:74-81. http:\/\/doi.org\/10.17925\/ENR.2013.08.02.74","DOI":"10.17925\/ENR.2013.08.02.74"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Brooks BR, Crumpacker D, Kaye RE et al. PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions. PLoS One. 2013;8(8):e72232. https:\/\/doi.org\/10.1371\/journal.pone.0072232","DOI":"10.1371\/journal.pone.0072232"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Work SS, Colamonico JA, Bradley WG, Kaye RE. Pseudobulbar affect: an under-recognized and under-treated neurological disorder. Adv Ther. 2011;28(7):586-601. https:\/\/doi.org\/10.1007\/s12325-011-0031-3","DOI":"10.1007\/s12325-011-0031-3"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Nabizadeh F, Nikfarjam M, Azami M et al. Pseudobulbar affect in neurodegenerative diseases: a systematic review and meta-analysis. J Clin Neurosci. 2022;100:100-7. https:\/\/doi.org\/10.1016\/j.jocn.2022.04.009","DOI":"10.1016\/j.jocn.2022.04.009"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Hakimi M, Maurer CW. Pseudobulbar affect in parkinsonian disorders: a review. J Mov Disord. 2019;12(1):14-21. https:\/\/doi.org\/10.14802\/jmd.18051","DOI":"10.14802\/jmd.18051"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Moore SR, Gresham LS, Bromberg MB et al. A self report measure of affective lability. J Neurol Neurosurg Psychiatry. 1997;63(1):89-93. https:\/\/doi.org\/10.1136\/jnnp.63.1.89","DOI":"10.1136\/jnnp.63.1.89"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Smith RA, Berg JE, Pope LE et al. Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients. Mult Scler. 2004;10(6):679-85. https:\/\/doi.org\/10.1191\/1352458504ms1106oa","DOI":"10.1191\/1352458504ms1106oa"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"M\u00f8ller M, Andersen G, Gjedde A. Serotonin 5HT1A receptor availability and pathological crying after stroke. Acta Neurol Scand. 2007;116(2):83-90. https:\/\/doi.org\/10.1111\/j.1600-0404.2007.00869.x","DOI":"10.1111\/j.1600-0404.2007.00869.x"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Brooks BR, Thisted RA, Appel SH et al. Treatment of pseudobulbar affect in ALS with dextromethorphan\/quinidine: a randomized trial. Neurology. 2004;63(8):1364-70. https:\/\/doi.org\/10.1212\/01.wnl.0000142042.50528.2f","DOI":"10.1212\/01.WNL.0000142042.50528.2F"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Quinn C, Edmundson C, Dahodwala N, Elman L. Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis. Muscle Nerve. 2020;61(4):508-11. https:\/\/doi.org\/10.1002\/mus.26764","DOI":"10.1002\/mus.26764"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000;25(24):3186-91. https:\/\/doi.org\/10.1097\/00007632-200012150-00014","DOI":"10.1097\/00007632-200012150-00014"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Sousa VD, Rojjanasrirat W. Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. J Eval Clin Pract. 2011;17(2):268-74. https:\/\/doi.org\/10.1111\/j.1365-2753.2010.01434.x","DOI":"10.1111\/j.1365-2753.2010.01434.x"}],"container-title":["Danish Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T14:05:12Z","timestamp":1757513112000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/dmj\/A07240497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":13,"URL":"https:\/\/doi.org\/10.61409\/a07240497","relation":{},"ISSN":["2245-1919"],"issn-type":[{"value":"2245-1919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}